During the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, the AML Hub spoke to Jacqueline Garcia, Dana-Farber Cancer Institute, Boston, US. We asked, Does the addition of venetoclax to low-dose conditioning improve outcome after allogeneic hematopoietic stem cell transplantation (allo-HSCT)?